The Importance of Thorough Preoperative Diagnostics of Maxillary Ameloblastoma: Report of Three Cases by Marko Matijević et al.
Coll. Antropol. 34 (2010) 4: 1445–1448
Case report
The Importance of Thorough Preoperative
Diagnostics of Maxillary Ameloblastoma:
Report of Three Cases
Marko Matijevi}, Dinko Leovi}, Bruno Popi}, Vedran Zub~i}, Vlatko Kopi}, Ante Prli}, Stjepan Siber
and Kristijan Dinjar
»J. J. Strossmayer« University, Osijek University Hospital Center, Department of Maxillofacial Surgery, Osijek, Croatia
A B S T R A C T
Ameloblastoma, especially maxillary, is a rare benign neoplasm of odontogenic origin. Diagnosis of significant num-
ber of lesions is usually established postoperatively, because ameloblastoma, especially the unicystic form, mimics wide
range of more frequent jaw lesions. From January 1993 to December 2005, three cases of the maxillary ameloblastoma
were surgically treated at our Department. The authors present clinical, radiological and pathohistological features of
the ameloblastomas in this rare localization with special attention to need of accurate preoperative diagnostics.
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Introduction
Intraosseous amelobastoma is the most common ag-
gressive odontogenic tumor, but still comparatively rare,
comprising only 1% of tumors and cysts arising in the
jaws1. They are divided into three types: intraosseous
solid or multicystic, intraosseous unicystic and periphe-
ral extraosseous form. Furthermore, upon the pathohi-
stological characteristics, solid ameloblastomas are sub-
divided into plexiform, acanthomatous, follicular, granu-
lar cell, desmoplastic and basoloid subgroups2,3. Eighty
per cent of ameloblastomas arise in the mandible, espe-
cially in their posterior parts, while approximately 20%
of the lesions arise in the maxilla4. Half of maxillary
ameloblastomas occur in molar area, involving the ma-
xillary sinus in 15% of cases4,5. Contrary to their mandib-
ular counterparts, maxillary ameloblastomas erode thin
compact bone much faster, invading the maxillary sinus,
nasal cavity and neighboring structures; orbit, infratem-
poral fossa, pterygopalatine fossa, buccal soft tissues etc.
Due to above mentioned reasons maxillary ameloblasto-
mas require surgical treatment as radical as cancers. If
not, the recurrences occur in 90–100% of cases and can
be fatal2,6. Proper surgical treatment should include at
least 10–15 mm of healthy bone7. Due to its rare occur-
rence and clinically unspecificity, the preoperative
diagnosis of maxillary ameloblastoma represents a lead-
ing problem. In this article we present own diagnostic er-
rors and difficulties and try to give advices for its avoid-
ance.
Report of Cases
From January 1993 to December 2005, three patients
with maxillary ameloblastoma have been treated at our
Department. In all three, the diagnosis was established
postoperatively. Also, in all, only routine laboratory tests
and conventional plain radiographs were performed.
Case 1
Twenty six year old female patient was admitted at
our Department in December 1995 due to firm, slowly
growing and painless tumor in the left upper oral vesti-
bule. Duration of the symptoms was five years. Intraoral
inspection and palpation revealed firm, well circumscri-
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bed, submucous lesion, 40mm in diameter, arising in the
region of canine and first premolar. The over lining mu-
cosa was normal. Although the tumorous appearance
was evident, due to poor dental status, the odontogenic
cyst was also taken in consideration. Radiographic image
revealed very unclear radiolucency in above mentioned
area (because of that reason the radiogram is not pre-
sented). Intraoperativelly, ameloblastous mixed appear-
ance (solid and cystic) was found. Complete resection of
the tumor, including safe bone margins was done. The
operation was diagnostic and therapeutic in the same
time. Pathohistological report described ameloblastoma
of typical follicular growth pattern. Eighty eight months
after the initial treatment the patient was without of any
clinical or radiographical signs of recurrence.
Case 2
A female patient, 69 year old, was referred in June
2001 due to swelling of the right upper oral vestibule
which has been lasted six months, without any subjective
complaints. Clinically, the tumor was palpable in the re-
gion of canine fossa, as well as in a whole right upper oral
vestibule, including a region of maxillary tuberosity. Pan-
oramic view revealed an oval tumor of inhomogeneous
density in above mentioned region (Figure 1). Tumor
was approached intraoraly and partial maxillectomy was
done. Pathohystologically, the ameloblastous appearance
with areas of a stromal sqamous metaplasia was found.
Differential diagnostically, the adamantinous type of a
craniopharyngeoma has been also taken in consider-
ation. To date, the patient is clinically and radiographi-
cally free of disease.
Case 3
Fifty seven year old male patient was referred in De-
cember 2002. due to surgical management of clinically
and radiographically typical cystic formation extending
to the left maxillary sinus, present at least 1, 5 years
(Figure 2). Clinically, the lack of the maxillary bone in
the area of the upper left wisdom tooth was obvious.
Also, the cystic formation was palpable submucously in
premolar and molar area. The preoperative diagnoses
were odontogenic cyst extending to maxillary sinus, mu-
cocelle or retentional maxillary sinus cyst. Caldwell-Luc
procedure and cyst evacuation was performed. Patho-
histological report revealed that, in fact, the whole lesion
was multicystic, and the basal cell growth pattern of
ameloblastoma was found. To date no recurrence, clini-
cally or radiologically, was noted during follow up.
Discussion
Solid/multicystic form of intraosseous ameloblastoma
is the most frequent and comprises 86% of all amelobla-
stomas, while unicystic lessions occur in 13%. The rest of
1% of ameloblastomas are peripheral ameloblastomas3.
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Fig. 1. Oval osseous tumor in the region of right maxillary tuber
showing tipical soap bubble radiographic appearance.
Fig. 2. Unicystic radiographic appearance of the ameloblastoma,
extending to the maxillary sinus and destroying the anterior and
lateral sinus walls which mimic radiographic appearance of the
mucocelle.
Fig. 3. Radilogical appearance of pathohistologically confirmed
retentional cyst of the maxillary antrum followed with bony
walls destruction, radiographically indistinguishable from ra-
diographic appearance of Case 3 (Figure 2).
Records addressing the problem of maxillary ameloblas-
toma are incoherent. Most reports are in forms of case
report studies8,9, some authors present their maxillary
ameloblastomas in overall series including mandibular
counterparts also6, many articles are focused to some ex-
clusive clinical or pathohistological variant etc.4,10,11. The-
re are very few reports about maxillary ameloblastoma in
whom the larger number of cases are presented12. Nastri
et al. report of scarcely 250 cases evaluated in the world
literature until 1993, while Reichart et al. report of 454
cases published until 19955,12. Such lack of accurate data
is the main reason why the true nature of this tumor is
still unclear. Because the same denominator in most in-
stances is a lack of preoperative diagnosis, it is obvious
that accurate preoperative diagnosis of ameloblastoma is
a top priority in the treatment plan. Larger lesion with
significant bone destruction and extension to neighbor-
ing structures generally are easier to be diagnosed. Due
to low suspicion index, the problem arises when we are
facing small lesion, or lesion mimicking odontogenic cyst
or cyst of maxillary sinus. For an example, Figure 3
shows pathologically proved cyst of the maxillary sinus
in other patient, which is radiographically indistinguish-
able from radiographic appearance of Case 3 (Figure 2).
This problem of diagnostics is reported by several au-
thors2,13. Also, ameloblastomas are not of specific struc-
ture clinically, nor radiographically. Solid ameloblasto-
mas are not necessary of radiologically multilocular or
soap bubble structure, as well as the unicystic ameloblas-
tomas are not always of unilocular appearance. Reichart
et al. found 15% of radiologically unilocular appearances
in 1234 ameloblastomas of the maxilla and mandible.
Among them, only 102 lesions have been verified as
unicystic forms pathohistologically5. Similarly, Li et al.,
in 20% of the pathohistologically confirmed unicystic
ameloblastomas found radiological multilocularity13. Con-
sequently, the misdiagnosis of the maxillary ameloblasto-
ma is not unusual and leads, due to insufficient safe bone
margins in surgical specimen, to unfavorable outcome.
In our series, all three cases have been either misdiag-
nosed (Case 3), under diagnosed (Case 1) or unrecog-
nized (Case 2). Thus, our series represents practically
the whole spectrum of possible diagnostic errors which
all finally resulted with absence of further diagnostic ef-
forts: CT/MR scanning and preoperative biopsy. The rea-
sons for that were too much everyday practice routine
behavior in the case of anteriorely located, well circum-
scribed, evidently benign tumor, without extension to
maxillary antrum (Case 1); typical misdiagnosing of the
cystic formation of the maxillary antrum which resem-
bled large odontogenic cyst, mucocelle or retentional
maxillary sinus cyst (Case 3); and even ignoration and
ununderstanding of evident clinical and radiographic
findings of ameloblastoma in a typical localization (Case
2). Accurate CT delineation of ameloblastoma extent is of
paramount importance, indicating adequate surgical ap-
proach which is a key of successful treatment, since re-
currences mostly occur in unrecognized and underdiag-
nosed patients2. Li et al., reviewing the clinicopathological
features in thirty three patients with unicystic maxillary
ameloblastoma, found six recurrences and all six were
misdiagnosed as odontogenic cysts preoperatively13. Ni-
nety five per cent of recurrences are detected within 5
years of initial treatment14, as well as half of recurrences
are usually find within 1 year postoperatively15. Although
all our patients are without any signs of disease, it does
not mean to be cured due to possibility of late recur-
rences, ten or more years after the initial treatment12.
Generally speaking, there is no place for enucleation in
treatment of amelobastoma. The only exception of this
rule is peripheral amelobastoma, a distinct type of tumor
arising in gingiva, predominantly in the mandible. Pe-
ripheral ameloblastoma is thought to arise from either
extraosseous remnants of dental lamina or the basal cell
layer of surface epithelium16. Peripheral ameloblastoma
is less common in maxilla, where the posterior tuberosity
is the most common site of occurrence. Extremely rare it
could be present in other sites of oral mucosa, except the
gingiva17,18. Limited number of the reports regarding pe-
ripheral amelobastoma treatment proved the local exci-
sion, extraosseous equivalent of enucleation, as a suffi-
cient treatment19. Other two types of ameloblastoma;
solid and unicystic, require more aggressive resection,
which usually includes 10–15 mm of healthy bone7. In
the case of the mandible it usually means segmental bone
resection, while in the case of the maxilla partial of even
total maxillectomy should be performed. Otherwise, the
reccurrence rate exceed 60–80 %20. This is especially true
for maxillary amelobastomas where reccurrences exceed
90–100 % if not treated radically2,6. The reason for such
aggressive surgical attitude lies in the fact that ame-
loblastic cells are usually find few millimeters beyond the
radiographic and clinical margins21. Indeed, there is no
reports in the recent literature regarding to the enu-
cleation or curettage in treatment of solid or multicystic
ameloblastoma20. The treatment of unicystic lesions is
more controversial. Enucleation of such ameloblastoma
could results with complete resection and free margins.
One should always keep in mind that there are three
pathohistological subtypes of unicystic ameloblastoma,
depending on whether they have simple odontogenic cys-
tic lining, a cystic lining which shows intraluminal plexi-
form proliferation, or a cystic lesion with invasion of sup-
porting connective tissue or even a bone (intramural type
of unicystic amelobastoma)22. Simple enucleation is obvi-
ously inadequate treatment for intramural type of unicy-
stic ameloblastoma and it will surely reccurr. Unfortu-
nately, the distinguishing of three types of unicystic
amelobalstoma is possible only retrospectively, from pa-
thohystological specimens11. Therefore, it is much safer
to radically resect all unicystic amelobalstic lesions, since
available diagnostic tools do not allow us to distinguish
unfavorable intramural form. Some reports propose com-
bination of enucleation and use of liquid nitrogen or tis-
sue fixatives, such as Carnoy’s solution, supposed to be
effective in elimination of cell remmants23–25. Such treat-
ment might be reserved for small, unicystic, completely
intrabony lesions and exclusively in the mandible. Be-
cause of anatomical considerations there is no place for
such treatment for maxillary ameloblastomas.
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Conclusion
Our limited experience leads us to conclude that any
maxillary osseous tumors or cysts, especially those suspi-
cious to ameloblastoma, as well as cysts larger then 35
mm require CT or MR evaluation. Special attention
should be paid to posteriorely located lesions. Also, pre-
operative biopsy of above mentioned lesions is manda-
tory. In cystic lesions, especially those associated with
loss of sinus walls, fine needle aspiration biopsy has been
proved as an accurate diagnostic method26. The above
mentioned recommendations and diagnostic strategy
could minimize unexpectable situations during a treat-
ment, as well as unfavorable outcomes.
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ZNA^AJ TEMELJITE PREOPERATIVNE DIJAGNOSTIKE AMELOBLASTOMA GORNJE ^ELJUSTI:
PRIKAZ TRI SLU^AJA
S A @ E T A K
Ameloblastom, posebice onaj smje{ten u gornjoj ~eljusti, je rijedak tumor odontogenog porijekla. Budu}i da amelo-
blastom, a naro~ito njegov unicisti~ni oblik, imitira puno u~estalije lezije ~eljusti, dijagnoza se u zna~ajnom broju ame-
loblastoma gornje ~eljusti postavi tek nakon operacije. Od sije~nja 1993. do prosinca 2005., na na{em Odjelu su kirur{ki
lije~ena tri bolesnika s ameloblastomom gornje ~eljusti. Autori iznose klini~ke, radiolo{ke i patohistolo{ke zna~ajke
ameloblastoma na ovoj rijetkoj lokalizaciji, uz poseban osvrt na zna~aj temeljite preoperativne dijagnostike.
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